EcoDrugPlus

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSSARG00000011076
Gene Symbol: F3
1 External references
243 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSSARG00000010305
Gene Symbol: F11
1 External references
216 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSSARG00000000993
Gene Symbol: CCDC6
1 External references
219 Possible Orthologues:

Complement C1s

Ensembl ID : ENSSARG00000006373
Gene Symbol: C1S
1 External references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSSARG00000007024
Gene Symbol: C5
1 External references
208 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSSARG00000014302
Gene Symbol: CDK1
1 External references
231 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSSARG00000011020
Gene Symbol: CDK4
1 External references
212 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSSARG00000006069
Gene Symbol: CDK6
1 External references
198 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSSARG00000003916
Gene Symbol: CYSLTR1
1 External references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSSARG00000010241
Gene Symbol: CDA
3 External references
224 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSSARG00000008499
Gene Symbol: CYP17A1
1 External references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSSARG00000000688
Gene Symbol: CYP19A1
1 External references
315 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).